Guideline K: Sponsorship

Reference: Standard 3 (#3.8) – Balanced, Evidence-Based, Fair and Objective

1. Application of /Guideline

1.1. This Guideline applies to all continuing pharmacy education learning activities, accredited by CCCEP or a CCCEP Accredited Provider, that are sponsored by an organization that is, or would
be deemed, a Limited-Privilege Provider.

1.2. The program provider submitting the learning activity to CCCEP for accreditation is responsible for applying this Guideline

[Top of Page]

2. Definition of Sponsorship

2.1. A sponsorship is a financial or in-kind contribution provided to a program provider to support the development, design, delivery, promotion, or evaluation of a continuing pharmacy
education learning activity.

2.2. Sponsorships may be:

     2.2.1. Directed – provided with the stipulation that the funds be used for a learning activity regarding a specified disease, medical condition, or subject area; or

     2.2.2. Non-directed – made available with general or no stipulations regarding their use, e.g., support for a conference, and allowing the recipient to determine the use of the funds within the grant’s guidelines.

[Top of Page]

3. Independent Control of Content

3.1. The program provider will maintain independent control over all aspects of the design and development of the educational learning activity.

3.2. To achieve this independent control, the program provider will undertake the following decisions and activities without any influence by the sponsor:

     3.2.1. Identification of continuing pharmacy education (CPE) needs;

    3.2.2. Determination of educational objectives;

     3.2.3. Selection of content;
     3.2.4. Hiring and compensation of all persons and organizations that decide on the content to include; and
     3.2.5. Selection of educational methods.

3.3. The provider may receive information from any source, including the learning activity sponsor, but will exercise due diligence to ensure:
     3.3.1. The validity and reliability of the information received;
     3.3.2. That all relevant evidence is reviewed and critically appraised, including unpublished studies;
     3.3.3. That Standard 3 (Balanced, Evidence-based, Fair and Objective) and Standard 5 (Disclosure and Bias) are met; and
     3.3.4. The appropriateness and application of the information to the learning activity.

4. Clear and Transparent Agreement

4.1. All interactions between program providers and sponsors will be conducted in an open and transparent manner and be guided by a sponsorship agreement that outlines the respective roles and responsibilities of the sponsor and program provider.

5. Funds Used for Education

5.1. The program provider will ensure that sponsorship funds are used solely for educational purposes and that neither the funds nor the learning activities are used to promote the specific interests, preferences, opinions or positions of the sponsor or any other supporting organization.

[Top of Page]

6. Sponsor Responsibilities

6.1. Sponsors will operate in accordance with the rights and privileges as outlined in the program provider policy for Full-Privilege or Limited-Privilege Providers, as appropriate. This includes the restrictions on the role of employees in the development and delivery of learning activities.

6.2. Employees of learning activity sponsors may introduce speakers in a Live Learning activity. The introduction may mention the company name but may not mention a product (drug, service, device or technology) of the company.

6.3. All provider and sponsor employees attending a Live Learning activity will identify themselves to the facilitator or chairperson, as appropriate.


[Top of Page]